The shift from tumor‐suppressive to tumor‐promoting functions is attributed to a decoupling of TGF‐β signaling from apoptotic pathways or the activation of non‐canonical pathways like PI3K‐AKT or Ras–ERK–MAPK [13, 14, 15, 16]. This evidence concerns the gene AKT1 and neoplasm.